Skip to main content

Advertisement

Log in

The neurotrophic factor Artemin promotes the motility and invasiveness of MIA PaCa-2 pancreatic cancer cells

  • Published:
The Chinese-German Journal of Clinical Oncology

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Objective

The aim of this study was to analyze the capacity of Artemin promoting the motility and invasiveness of MIA PaCa-2 pancreatic cancer (PAC) cells.

Methods

The PAC cell line MIA PaCa-2 was cultured in vitro and studied using Transwell chamber analysis. The motility and invasiveness ability affected by different concentrations of Artemin and its receptor GFRα3 were determined. Expression level of matrix metalloproteinase-2 (MMP-2), epithelial cadherin (E-cadherin) were quantitative analysis using RT-PCR and Western blot in MIA PaCa-2 cells stimulated with Artemin and receptor GFRα3.

Results

MIA PaCa-2 PAC cell motility and invasiveness was significantly increased with Artemin and its receptor GFRα3 increasing concentrations than control (P < 0.01). 150 ng/mL was the best of both the role of concentration. MMP-2 was increased significantly (t = 6.35, t = 7.32), while E-cadherin was significantly lower (t = 4.27, t = 5.61), after affected by the 150 ng/mL Artemin and GFRα3, respectively. The difference was statistically significant compared with the control group (P < 0.01).

Conclusion

Artemin and its receptor GFRα3 can promote PAC cell motility and invasiveness ability and contribute to the aggressive behavior. The mechanism may be related to increased expression of MMP-2 molecule and E-cadherin down-regulation expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59: 225–249.

    Article  PubMed  Google Scholar 

  2. Lomberk G. Pain management. Pancreatology, 2008, 8: 542–543.

    Article  PubMed  Google Scholar 

  3. Airaksinen MS, Holm L, Hätinen T. Brain Behav Evol, 2006, 68: 181–190.

    Article  PubMed  Google Scholar 

  4. Rückert F, Görgens H, Richter I, et al. RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system. Int J Colorectal Dis, 2011, 26: 835–840.

    Article  PubMed  Google Scholar 

  5. Meng LX, LI Q, Xue YJ, et al. Effects of nerve growth factor on invasive ability of human pancreatic cancer cell line MIA PaCa-2. Chin J Hepatobiliary Surg (Chinese), 2008, 14: 796–800.

    CAS  Google Scholar 

  6. Okada Y, Takeyama H, Sato M, et al. Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret protooncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF). Int J Cancer, 1999, 81: 67–73.

    Article  PubMed  CAS  Google Scholar 

  7. Baloh RH, Tansey MG, Lampe PA, et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron, 1998, 21: 1291–1302.

    Article  PubMed  CAS  Google Scholar 

  8. Enomoto H, Crawford PA, Gorodinsky A, et al. RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development, 2001, 128: 3963–3974.

    PubMed  CAS  Google Scholar 

  9. Honma Y, Araki T, Gianino S, et al. Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron, 2002, 35: 267–282.

    Article  PubMed  CAS  Google Scholar 

  10. Andres R, Forgie A, Wyatt S, et al. Multiple effects of artemin on sympathetic neurone generation, survival and growth. Development, 2001, 128: 3685–3695.

    PubMed  CAS  Google Scholar 

  11. Baloh RH, Tansey MG, Johnson EM, et al. Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFRalpha1 RET-specific agonists. J Biol Chem, 2000, 275: 3412–3420.

    Article  PubMed  CAS  Google Scholar 

  12. Ceyhan GO, Giese NA, Erkan M, et al. The neurotrophic factor artemin promotes pancreatic cancer invasion. Ann Surg, 2006, 244: 274–281.

    Article  PubMed  Google Scholar 

  13. Orozco OE, Walus L, Sah DW, et al. GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Eur J Neurosci, 2001, 13: 2177–2182.

    Article  PubMed  CAS  Google Scholar 

  14. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev, 2001, 12: 361–373.

    Article  PubMed  CAS  Google Scholar 

  15. Terada T, Okada Y, Nakanuma Y. Expression of matrix proteinases during human intrahepatic bile duct development. A possible role in biliary cell migration. Am J Pathol, 1995, 147: 1207–1213.

    PubMed  CAS  Google Scholar 

  16. Jo Chae K, Rha SY, Oh BK, et al. Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma. Am J Gastroenterol, 2004, 99: 68–75.

    Article  PubMed  Google Scholar 

  17. McLaughlin RB, Montone KT, Wall SJ, et al. Nerve cell adhesion molecule expression in squamous cell carcinoma of the head and neck: a predictor of propensity toward perineural spread. Laryngoscope, 1999, 109: 821–826.

    Article  PubMed  Google Scholar 

  18. von Burstin J, Eser S, Paul MC, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology, 2009, 137: 361–371.

    Article  Google Scholar 

  19. Torer N, Kayaselcuk F, Nursal TZ, et al. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J Surg Oncol, 2007, 96: 419–423.

    Article  PubMed  Google Scholar 

  20. Winter JM, Ting AH, Vilardell F, et al. Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res, 2008, 14: 412–418.

    Article  PubMed  CAS  Google Scholar 

  21. Kao WT, Lin CY, Lee LT, et al. Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res, 2008, 28: 2109–2120.

    PubMed  CAS  Google Scholar 

  22. Veit C, Genze F, Menke A, et al. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res, 2004, 64: 5291–5300.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lingxin Meng.

Additional information

Supported by grants from the National Science Foundation of Shandong Province (No. ZR2010HL053) and the Surface Project of Jining Medical University

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meng, L., Chi, Y., Wang, X. et al. The neurotrophic factor Artemin promotes the motility and invasiveness of MIA PaCa-2 pancreatic cancer cells. Chin. -Ger. J. Clin. Oncol. 11, 219–223 (2012). https://doi.org/10.1007/s10330-011-0955-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-011-0955-8

Key words

Navigation